Option Millionaires

[uranium-pinto-beans]

$CREE

Cree weakness a buying opportunity, says Goldman at Goldman
Goldman said said Cree reported a solid Q3 but margins and a weaker EPS outlook are pressuring shares. The firm is encouraged by top-line trends and continues to believe potential leverage is unappreciated while noting all segments are growing into June and guided higher capex to ease capacity constraints. The analyst would use weakness as a buying opportunity and maintains tis Buy rating but lowered its price target to $66 from $72